Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C

NCT00200343 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

596

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Ursodeoxycholic acid 150mg / day
DRUG: Ursodeoxycholic acid 600mg / day
DRUG: Ursodeoxycholic acid 900mg / day

Sponsor

Tanabe Pharma Corporation